Cytophage Technologies Ltd. (TSXV:CYTO)

Canada flag Canada · Delayed Price · Currency is CAD
0.110
+0.015 (15.79%)
At close: Mar 6, 2026
-46.34%
Market Cap 7.45M
Revenue (ttm) n/a
Net Income (ttm) -4.57M
Shares Out 67.69M
EPS (ttm) -0.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,000
Average Volume 47,124
Open 0.110
Previous Close 0.095
Day's Range 0.110 - 0.110
52-Week Range 0.075 - 0.395
Beta -0.21
RSI 42.10
Earnings Date Apr 30, 2026

About Cytophage Technologies

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Steven Theriault
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol CYTO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.